Bulimia Nervosa
📧 Sign up to get email alerts when something new happens for Bulimia Nervosa.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2023-08-18FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc.
-
FDA label_change · 2023-08-18FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for Fluoxetine to update the labeling. The applicant is Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for the generic fluoxetine from Aurobindo Pharma Limited, allowing continued marketing of a fluo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for fluoxetine hydrochloride from Endo USA, Inc.
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved a supplemental application for a ScieGen Pharmaceuticals generic fluoxetine product under anANDA process.
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for fluoxetine hydrochloride submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for fluoxetine hydrochloride from Dr. Reddy's Laboratories Limited. This is an approved amendmen…
-
FDA approval · 2023-08-18FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine hydrochloride from Alembic Pharmaceuticals Limited.
-
FDA approval · 2023-08-10FDA Approved: FLUOXETINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine from Torrent Pharmaceuticals Limited, enabling the generic antidepressant to be manuf…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. [Phase 4]
Phase 4 clinical trial evaluating efficacy of serotonergic antidepressants in bulimia nervosa guided by brain serotonin profile via PET imag…
-
FDA approval · 2022-11-15FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith's fluoxetine hydrochloride as an original generic application, allowing the generic product to be marketed wit…
-
FDA approval · 2022-11-09FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' original application for fluoxetine hydrochloride, a generic version of fluoxetine.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Binge Eating & Birth Control [Phase 2]
Phase 2 clinical trial update for a study on binge eating and birth control in bulimia nervosa/binge eating disorders; study terminated with…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Neurobiology of Bulimia Nervosa [Phase 2]
Phase 2 clinical trial investigating the neurobiology of bulimia nervosa; completed with results posted in 2022.
-
FDA approval · 2022-03-29FDA Approved: FLUOXETINE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for a generic fluoxetine product.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
A completed fMRI study evaluating self-regulation in adolescents with bulimia nervosa; results posted in 2021.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Fluoxetine Hydrochloride from Lannett Company, Inc., a generic fluoxetine product.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma. The approval updates the…
-
FDA approval · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine submitted by Torrent Pharmaceuticals Limited.
-
FDA label_change · 2021-09-21FDA Approved: FLUOXETINE — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved a supplemental application for fluoxetine by ScieGen Pharmaceuticals to update the labeling for this generic antidepressant.
-
FDA approval · 2021-09-20FDA Approved: FLUOXETINE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
The FDA approved a supplemental application for fluoxetine from Saptalis Pharmaceuticals, LLC., enabling a generic fluoxetine product under …
-
FDA approval · 2021-09-20FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, granting approval of a generic fluoxetine product.